MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
KLRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kalaris Therapeutics (KLRS) Ownership - Who owns Kalaris Therapeutics?

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
104.69M
P/E Ratio
N/A
Total Cash
97.22M
Projected Growth
N/A
Total Debt
1.41M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.09
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
KLRS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for KLRS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details